Latest stories on CNSP
Corero Network Security plc 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
StockTitan56 · neutralproduct/pr
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
StockTitan56 · neutralproduct/pr
CNS Pharmaceuticals ‘actively evaluating’ business devlopment opportunities
The Fly56 · neutralgeneral
CNS Pharmaceuticals GAAP EPS of -$0.37 misses by $0.13
Seeking Alpha34 · bearishearnings
This AI Infrastructure Stock Could Benefit From a Connection Crisis
The Motley Fool63 · neutralproduct/pr
CNS Pharmaceuticals Announces Strategic Oncology-Neurology Realignment
TipRanks56 · neutralgeneral
CNS Pharmaceuticals, Inc. (CNSP) files 8-K
SEC 8-K50 · neutralgeneral
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
Yahoo Finance64 · neutralanalyst
CNS Pharmaceuticals reports Q1 results
Seeking Alpha50 · neutralearnings